The ADC targets Nectin-4 on tumor cells, is internalized, and releases a tubulin inhibitor (AP052) that blocks microtubule polymerization, leading to G2/M arrest and apoptosis; Fc effector functions may contribute. Tubulin expression alone does not make cells targets for the drug.